Q3 2026
Nov 1, 2026
Align reported Q3 revenue of $1.015 billion, up 1.9% year over year, with Clear Aligner shipments up 6.6%; the stock was essentially flat at +0.1%. Gross margin came in modestly below the company’s expectation, while operating margin was above its outlook.
Key takeaways
- Clear Aligner shipments rose 6.6% to 691,000, at the high end of the company’s expected mid-single-digit growth; record doctor submitters reached 91,000, up more than 3%.
- Systems and Services revenue fell 7.6% to $175.5 million, reflecting a shift toward lower-priced scanner configurations and more flexible acquisition models.
- Non-GAAP gross margin was 70.4%, modestly below expectation due to higher fuel-related transportation costs, lower Clear Aligner ASP and geographic and product mix. Non-GAAP operating margin was 24.4%, above outlook.
- Americas Clear Aligner shipments increased approximately 1.5%; North American DSO shipments grew at a double-digit rate, while the broader retail channel remained pressured, particularly among GP customers.
- Worldwide Zero Additional Aligner volume increased at a triple-digit rate year over year; international younger-patient shipments grew at a double-digit rate.
Q2 2026
Jul 31, 2026
Shares declined 1.2% as investors digested softness in the Systems and Services segment driven by lower scanner ASPs and cautious commentary about near-term revenue headwinds from new lower-cost scanner purchasing options, despite stable Clear Aligner volumes and better-than-expected margins.
Key takeaways
- Clear Aligner revenue grew 8.2% year-over-year, with volume reaching a record 692,000 cases, up 7.4%, supporting ongoing global adoption across multiple customer channels and regions.
- Non-GAAP operating margin improved to 22.9%, surpassing internal expectations, helped by mix and efficiency in Clear Aligners.
- Systems and Services revenue declined 11% year-over-year to $185.3 million due to price pressure from a shift to lower-priced scanners and flexible acquisition models, including leasing and rental options.
- While scanner unit placements and active installed base grew double digits, rental and lease programs are creating near-term revenue and profitability headwinds.
- Management underscored the intentional strategic shift to expand longer-term recurring revenue and platform adoption at the cost of short-term sales pressure in capital equipment.
Q1 2026
Apr 30, 2026
Align shares closed down 0.7% post-earnings, indicating a fairly muted investor reaction despite management highlighting year-over-year growth in key segments. Solid Clear Aligner volumes and international growth were balanced by a sequential decline in Systems & Services and overall margin commentary that did not notably exceed expectations.
Key takeaways
- Q1 revenue was $1.04 billion, up 6.2% year-over-year, primarily driven by Clear Aligner volumes and higher ASPs.
- Clear Aligner shipments reached a quarterly record of 686,000 cases, up 6.7% year-over-year, and Clear Aligner revenue grew 7.4% to $856 million.
- All major regions saw double-digit Clear Aligner volume growth except North America, which remained stable.
- Systems and Services revenue totaled $184 million, up 1% year-over-year but declined sequentially, reflecting anticipated capital equipment seasonality and a continued mix shift toward lower-priced scanner offerings.
- Doctor utilization and the number of submitting doctors both increased globally, though topline and segment trends appeared largely in line with expectations, as reflected by the modest market move.
Q3 2025
Oct 30, 2025
Align Technology's Q3 2025 results surpassed expectations with growth in Clear Aligner volumes, particularly driven by international markets, while Systems and Services revenues faced anticipated declines.
Key takeaways
- Q3 total revenues reached $996 million, marking a 1.8% year-over-year increase, driven primarily by Clear Aligner sales.
- Clear Aligner revenues of $806 million increased by 2.4% year-over-year, with case volumes up 5% to 648,000.
- Non-GAAP operating margin improved to 23.9%, exceeding the anticipated 22%.
- Active iTero system installations grew 12% year-over-year, with over 120,000 units globally enhancing digital technology access for practitioners.
- Continued demand for new product innovations in digital dental solutions aims to improve patient engagement and conversion rates.
Q2 2025
Aug 1, 2025
Align Technology reported mixed Q2 results with total revenues of $1.12 billion, driven by strong sales in the Systems and Services segment, though revenues in clear aligners fell short due to lower demand in North America and Europe.
Key takeaways
- Q2 revenues increased by 3.4% sequentially but fell 1.6% year-over-year, reflecting a strong performance in iTero Lumina upgrades despite a downturn in clear aligners.
- The company faced challenges from lower-than-expected orthodontic starts and consumer hesitancy influenced by economic uncertainty and tariff disruptions.
- Notable growth in certain product segments, such as Invisalign First and DSP touch-up cases, with a record number of doctors utilizing their products.
- Clear aligner volume decreased slightly in North America year-over-year but grew in EMEA and APAC, indicating regional variations in demand.
- Align is strategically focusing on enhancing commercial engagement and managing costs in response to market conditions.